KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Minority Interest (2020 - 2022)

Historic Minority Interest for Ginkgo Bioworks Holdings (DNA) over the last 3 years, with Q3 2022 value amounting to $5.0 million.

  • Ginkgo Bioworks Holdings' Minority Interest fell 9247.21% to $5.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $5.0 million, marking a year-over-year decrease of 9247.21%. This contributed to the annual value of $62.0 million for FY2021, which is 61477.64% up from last year.
  • According to the latest figures from Q3 2022, Ginkgo Bioworks Holdings' Minority Interest is $5.0 million, which was down 9247.21% from $31.6 million recorded in Q2 2022.
  • In the past 5 years, Ginkgo Bioworks Holdings' Minority Interest ranged from a high of $66.4 million in Q3 2021 and a low of $5.0 million during Q3 2022
  • Over the past 3 years, Ginkgo Bioworks Holdings' median Minority Interest value was $32.4 million (recorded in 2022), while the average stood at $34.5 million.
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Minority Interest surged by 61477.64% in 2021 and then plummeted by 9247.21% in 2022.
  • Ginkgo Bioworks Holdings' Minority Interest (Quarter) stood at $8.7 million in 2020, then skyrocketed by 614.78% to $62.0 million in 2021, then tumbled by 91.94% to $5.0 million in 2022.
  • Its Minority Interest stands at $5.0 million for Q3 2022, versus $31.6 million for Q2 2022 and $33.3 million for Q1 2022.